Deerfield Management Company, L.P. (Series C) Morpho Sys Ag Transaction History

Deerfield Management Company, L.P. (Series C)

  • $4.84 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$26.07 - $36.32 $3.25 Million - $4.53 Million
-124,701 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$24.18 - $31.58 $11.5 Million - $15 Million
-475,299 Reduced 79.22%
124,701 $3.43 Million
Q2 2018

Aug 14, 2018
BUY
$25.15 - $30.6 $15.1 Million - $18.4 Million
600,000 New
600,000 $18.2 Million

Others Institutions Holding MOR

# of Institutions
72
Shares Held
11.3M
Call Options Held
320K
Put Options Held
1.1M
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Market Cap $2.54B
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email